The Enterprise Value as of November 2025 (TTM) for DMK Pharmaceuticals Corporation (DMKPQ) is -737792.00

According to DMK Pharmaceuticals Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is -737792.00. This represents a change of -43.56% compared to the average of -1307103.65 of the last 4 quarters.

DMK Pharmaceuticals Corporation (DMKPQ) Historical Enterprise Value (quarterly & annually)

How has DMKPQ Enterprise Value performed in the past?

The mean historical Enterprise Value of DMK Pharmaceuticals Corporation over the last ten years is -1750027.06. The current -737792.00 Enterprise Value has changed 4.12% with respect to the historical average. Over the past ten years (40 quarters), DMKPQ's Enterprise Value was at its highest in in the December 2022 quarter at 1.80M. The Enterprise Value was at its lowest in in the June 2021 quarter at -15834893.00.

DMK Pharmaceuticals Corporation (DMKPQ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of DMK Pharmaceuticals Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

DMK Pharmaceuticals Corporation (DMKPQ) Average Enterprise Value

How has DMKPQ Enterprise Value performed in the past?

The current Enterprise Value of DMK Pharmaceuticals Corporation (DMKPQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

DMK Pharmaceuticals Corporation (DMKPQ) Enterprise Value vs. Peers

How is DMKPQ’s Enterprise Value compared to its peers?

DMK Pharmaceuticals Corporation’s Enterprise Value is less than IMV Inc. (7.67M), less than BioELife Corp. (277.38K), less than Millennium Sustainable Ventures Corp. (40.72M), less than eFFECTOR Therapeutics, Inc. (5.67M), less than HLK Biotech Holding Group, Inc. (0), greater than ContraFect Corporation (-6024930.00), less than BIMI International Medical Inc. (3.12M), less than Minerva Surgical, Inc. (32.76M), less than American Medical Technologies Inc. (480.66K), less than Omnimmune Holdings, Inc. (2.27M),

Build a custom stock screener for DMK Pharmaceuticals Corporation (DMKPQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DMK Pharmaceuticals Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DMK Pharmaceuticals Corporation (DMKPQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DMK Pharmaceuticals Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.